{"id":522825,"date":"2021-08-04T07:04:33","date_gmt":"2021-08-04T11:04:33","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-report-second-quarter-2021-financial-results-on-august-11-2021\/"},"modified":"2021-08-04T07:04:33","modified_gmt":"2021-08-04T11:04:33","slug":"adma-biologics-to-report-second-quarter-2021-financial-results-on-august-11-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-report-second-quarter-2021-financial-results-on-august-11-2021\/","title":{"rendered":"ADMA Biologics to Report Second Quarter 2021 Financial Results on August 11, 2021"},"content":{"rendered":"<h2>\nConference Call Scheduled for August 11, 2021 at 4:30 p.m. ET<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p align=\"left\">RAMSEY, N.J. and BOCA RATON, Fla., Aug.  04, 2021  (GLOBE NEWSWIRE) &#8212; ADMA Biologics, Inc. (Nasdaq: ADMA) (\u201cADMA\u201d or the \u201cCompany\u201d), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced that it will report financial results for the second quarter ended June 30, 2021 on Wednesday, August 11, 2021 after the U.S. financial markets close. \u00a0ADMA\u2019s management team will host a live conference call and audio webcast on that date at 4:30 p.m. ET to discuss its financial results and other Company updates.<\/p>\n<p>To access the conference call, please dial (855) 884-8773 (local) or (615) 622-8043 (international) at least 10 minutes prior to the start time and refer to conference ID 8992329. A live audio webcast of the call will be available under \u201cEvents &amp; Webcasts\u201d in the investor section of the Company\u2019s website, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=6N8pjmNKDwn9wy82KIAbo7920uZTLu8wbt_YcXSkXxGSSTnPJ2zvdpGucveBmIZZMsNd8cxwIpx5LyAggXoBsr1Li7nDEvk7LNHN7DszN5zJfgunJNdtysmAHHDr648GRjAZ2H5Oh7HRZKAu5z4fhg==\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/ir.admabiologics.com\/events-webcasts<\/a>. An archived webcast will be available on the Company\u2019s website approximately two hours after the event.<\/p>\n<p align=\"justify\">\n        <strong>About ADMA Biologics, Inc. (ADMA) <\/strong>\n      <\/p>\n<p align=\"justify\">ADMA Biologics is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. ADMA currently manufactures and markets three United States Food and Drug Administration (FDA)-approved plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain infectious diseases: ASCENIV\u2122 (immune globulin intravenous, human \u2013 slra 10% liquid) for the treatment of primary humoral immunodeficiency (PI); BIVIGAM\u00ae (immune globulin intravenous, human) for the treatment of PI; and NABI-HB\u00ae (hepatitis B immune globulin, human) to provide enhanced immunity against the hepatitis B virus. ADMA manufactures its immune globulin products at its FDA-licensed plasma fractionation and purification facility located in Boca Raton, Florida. Through its ADMA BioCenters subsidiary, ADMA also operates as an FDA-approved source plasma collector in the U.S., which provides a portion of its blood plasma for the manufacture of its products. ADMA\u2019s mission is to manufacture, market and develop specialty plasma-derived, human immune globulins targeted to niche patient populations for the treatment and prevention of certain infectious diseases and management of immune compromised patient populations who suffer from an underlying immune deficiency, or who may be immune compromised for other medical reasons. ADMA has received U.S. Patents: 9,107,906, 9,714,283, 9,815,886, 9,969,793 and 10,259,865 related to certain aspects of its products and product candidates. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=uSGQZi30Szpoa6mvxoKh6bsPxHOP9LyDMcLQSVGIkwJJgTmSiW5SX5WlvFMyf1DE9Nnx_xHfphOBoMakHxZF9heRWORnPuKiDFHB5B5ZY0c=\" rel=\"nofollow noopener\" target=\"_blank\">www.admabiologics.com<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>COMPANY CONTACT:<br \/><\/strong>Skyler Bloom<br \/>Director, Investor Relations and Corporate Strategy | 201-478-5552 |\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=g7BHXQvxSSxxVXd65wU42a74cabZpU63sURgR8mRtZrmWx48c1c6c3ni6PPrkr690eXlXf-JLK-SuIod9eShmkS169yeG7xcy0WkZOkDKWU=\" rel=\"nofollow noopener\" target=\"_blank\">sbloom@admabio.com<\/a><\/p>\n<p align=\"justify\">\n        <strong>INVESTOR RELATIONS CONTACT:<br \/><\/strong>Michelle Pappanastos<br \/>Senior Managing Director, Argot Partners | 212-600-1902 | <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=EcvBmUOsY54F3bHWlHZk7ZdD2mgK_3DMLFddKg65IyQ-BavCf5C3MPfLnhNnL-6jAU1BYYb-N2-04gpEBhUQFVYvCdVsXvNZRXfDvR_0e_Q=\" rel=\"nofollow noopener\" target=\"_blank\">michelle@argotpartners.com<\/a><\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMjMwMCM0MzM5Nzc3IzIwMjM3MzA=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/8f5438c7-1087-47ad-ba47-88ef19af86fe\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Conference Call Scheduled for August 11, 2021 at 4:30 p.m. ET RAMSEY, N.J. and BOCA RATON, Fla., Aug. 04, 2021 (GLOBE NEWSWIRE) &#8212; ADMA Biologics, Inc. (Nasdaq: ADMA) (\u201cADMA\u201d or the \u201cCompany\u201d), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced that it will report financial results for the second quarter ended June 30, 2021 on Wednesday, August 11, 2021 after the U.S. financial markets close. \u00a0ADMA\u2019s management team will host a live conference call and audio webcast on that date at 4:30 p.m. ET to discuss its financial results and other Company updates. To access the conference call, please dial (855) 884-8773 (local) or (615) 622-8043 (international) at least 10 minutes prior &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-report-second-quarter-2021-financial-results-on-august-11-2021\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ADMA Biologics to Report Second Quarter 2021 Financial Results on August 11, 2021&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-522825","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ADMA Biologics to Report Second Quarter 2021 Financial Results on August 11, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-report-second-quarter-2021-financial-results-on-august-11-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ADMA Biologics to Report Second Quarter 2021 Financial Results on August 11, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Conference Call Scheduled for August 11, 2021 at 4:30 p.m. ET RAMSEY, N.J. and BOCA RATON, Fla., Aug. 04, 2021 (GLOBE NEWSWIRE) &#8212; ADMA Biologics, Inc. (Nasdaq: ADMA) (\u201cADMA\u201d or the \u201cCompany\u201d), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced that it will report financial results for the second quarter ended June 30, 2021 on Wednesday, August 11, 2021 after the U.S. financial markets close. \u00a0ADMA\u2019s management team will host a live conference call and audio webcast on that date at 4:30 p.m. ET to discuss its financial results and other Company updates. To access the conference call, please dial (855) 884-8773 (local) or (615) 622-8043 (international) at least 10 minutes prior &hellip; Continue reading &quot;ADMA Biologics to Report Second Quarter 2021 Financial Results on August 11, 2021&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-report-second-quarter-2021-financial-results-on-august-11-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-04T11:04:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMjMwMCM0MzM5Nzc3IzIwMjM3MzA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-biologics-to-report-second-quarter-2021-financial-results-on-august-11-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-biologics-to-report-second-quarter-2021-financial-results-on-august-11-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ADMA Biologics to Report Second Quarter 2021 Financial Results on August 11, 2021\",\"datePublished\":\"2021-08-04T11:04:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-biologics-to-report-second-quarter-2021-financial-results-on-august-11-2021\\\/\"},\"wordCount\":442,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-biologics-to-report-second-quarter-2021-financial-results-on-august-11-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwMjMwMCM0MzM5Nzc3IzIwMjM3MzA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-biologics-to-report-second-quarter-2021-financial-results-on-august-11-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-biologics-to-report-second-quarter-2021-financial-results-on-august-11-2021\\\/\",\"name\":\"ADMA Biologics to Report Second Quarter 2021 Financial Results on August 11, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-biologics-to-report-second-quarter-2021-financial-results-on-august-11-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-biologics-to-report-second-quarter-2021-financial-results-on-august-11-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwMjMwMCM0MzM5Nzc3IzIwMjM3MzA=\",\"datePublished\":\"2021-08-04T11:04:33+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-biologics-to-report-second-quarter-2021-financial-results-on-august-11-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-biologics-to-report-second-quarter-2021-financial-results-on-august-11-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-biologics-to-report-second-quarter-2021-financial-results-on-august-11-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwMjMwMCM0MzM5Nzc3IzIwMjM3MzA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwMjMwMCM0MzM5Nzc3IzIwMjM3MzA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adma-biologics-to-report-second-quarter-2021-financial-results-on-august-11-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ADMA Biologics to Report Second Quarter 2021 Financial Results on August 11, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ADMA Biologics to Report Second Quarter 2021 Financial Results on August 11, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-report-second-quarter-2021-financial-results-on-august-11-2021\/","og_locale":"en_US","og_type":"article","og_title":"ADMA Biologics to Report Second Quarter 2021 Financial Results on August 11, 2021 - Market Newsdesk","og_description":"Conference Call Scheduled for August 11, 2021 at 4:30 p.m. ET RAMSEY, N.J. and BOCA RATON, Fla., Aug. 04, 2021 (GLOBE NEWSWIRE) &#8212; ADMA Biologics, Inc. (Nasdaq: ADMA) (\u201cADMA\u201d or the \u201cCompany\u201d), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced that it will report financial results for the second quarter ended June 30, 2021 on Wednesday, August 11, 2021 after the U.S. financial markets close. \u00a0ADMA\u2019s management team will host a live conference call and audio webcast on that date at 4:30 p.m. ET to discuss its financial results and other Company updates. To access the conference call, please dial (855) 884-8773 (local) or (615) 622-8043 (international) at least 10 minutes prior &hellip; Continue reading \"ADMA Biologics to Report Second Quarter 2021 Financial Results on August 11, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-report-second-quarter-2021-financial-results-on-august-11-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-08-04T11:04:33+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMjMwMCM0MzM5Nzc3IzIwMjM3MzA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-report-second-quarter-2021-financial-results-on-august-11-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-report-second-quarter-2021-financial-results-on-august-11-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ADMA Biologics to Report Second Quarter 2021 Financial Results on August 11, 2021","datePublished":"2021-08-04T11:04:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-report-second-quarter-2021-financial-results-on-august-11-2021\/"},"wordCount":442,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-report-second-quarter-2021-financial-results-on-august-11-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMjMwMCM0MzM5Nzc3IzIwMjM3MzA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-report-second-quarter-2021-financial-results-on-august-11-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-report-second-quarter-2021-financial-results-on-august-11-2021\/","name":"ADMA Biologics to Report Second Quarter 2021 Financial Results on August 11, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-report-second-quarter-2021-financial-results-on-august-11-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-report-second-quarter-2021-financial-results-on-august-11-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMjMwMCM0MzM5Nzc3IzIwMjM3MzA=","datePublished":"2021-08-04T11:04:33+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-report-second-quarter-2021-financial-results-on-august-11-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-report-second-quarter-2021-financial-results-on-august-11-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-report-second-quarter-2021-financial-results-on-august-11-2021\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMjMwMCM0MzM5Nzc3IzIwMjM3MzA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMjMwMCM0MzM5Nzc3IzIwMjM3MzA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adma-biologics-to-report-second-quarter-2021-financial-results-on-august-11-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ADMA Biologics to Report Second Quarter 2021 Financial Results on August 11, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/522825","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=522825"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/522825\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=522825"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=522825"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=522825"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}